• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对因其他诊断而住院的患者进行 SARS-CoV-2 筛查的诊断收益:一项观察性队列研究。

Diagnostic yield of screening for SARS-CoV-2 among patients admitted to hospital for alternate diagnoses: an observational cohort study.

机构信息

Department of Emergency Medicine, University of Saskatchewan, Saskatchewan, Saskatoon, Canada

Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.

出版信息

BMJ Open. 2022 Aug 10;12(8):e057852. doi: 10.1136/bmjopen-2021-057852.

DOI:10.1136/bmjopen-2021-057852
PMID:35948378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9378945/
Abstract

OBJECTIVES

To determine the diagnostic yield of screening patients for SARS-CoV-2 who were admitted with a diagnosis unrelated to COVID-19 and to identify risk factors for positive tests.

DESIGN

Cohort from the Canadian COVID-19 Emergency Department Rapid Response Network registry.

SETTING

30 acute care hospitals across Canada.

PARTICIPANTS

Patients hospitalised for non-COVID-19-related diagnoses who were tested for SARS-CoV-2 between 1 March and 29 December 2020.

MAIN OUTCOME

Positive nucleic acid amplification test for SARS-CoV-2.

OUTCOME MEASURE

Diagnostic yield.

RESULTS

We enrolled 15 690 consecutive eligible adults who were admitted to hospital without clinically suspected COVID-19. Among these patients, 122 tested positive for COVID-19, resulting in a diagnostic yield of 0.8% (95% CI 0.64% to 0.92%). Factors associated with a positive test included presence of fever, being a healthcare worker, having a positive household contact or institutional exposure, and living in an area with higher 7-day average incident COVID-19 cases.

CONCLUSIONS

Universal screening of hospitalised patients for COVID-19 across two pandemic waves had a low diagnostic yield and should be informed by individual-level risk assessment in addition to regional COVID-19 prevalence.

TRIAL REGISTRATION NUMBER

NCT04702945.

摘要

目的

确定对因非 COVID-19 相关诊断而住院的患者进行 SARS-CoV-2 筛查的诊断收益,并确定阳性检测的危险因素。

设计

来自加拿大 COVID-19 急诊部快速反应网络登记处的队列研究。

地点

加拿大 30 家急性护理医院。

参与者

2020 年 3 月 1 日至 12 月 29 日期间因非 COVID-19 相关诊断住院且接受 SARS-CoV-2 检测的患者。

主要结局

SARS-CoV-2 核酸扩增检测阳性。

结局指标

诊断收益。

结果

我们纳入了 15690 名连续符合条件的成年人,他们在没有临床疑似 COVID-19 的情况下住院。在这些患者中,有 122 例 COVID-19 检测呈阳性,诊断收益为 0.8%(95%CI 0.64%至 0.92%)。与阳性检测相关的因素包括发热、医护人员、有阳性家庭接触者或机构暴露史,以及居住在 COVID-19 7 天平均发病率较高的地区。

结论

在两次大流行浪潮中对住院患者进行 COVID-19 普遍筛查的诊断收益较低,除了 COVID-19 流行率外,还应根据个体风险评估来确定。

临床试验注册号

NCT04702945。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/9378945/464f02fa0cd9/bmjopen-2021-057852f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/9378945/9e0cc90ebde4/bmjopen-2021-057852f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/9378945/3a9a2e5d152f/bmjopen-2021-057852f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/9378945/53341f6c4f86/bmjopen-2021-057852f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/9378945/464f02fa0cd9/bmjopen-2021-057852f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/9378945/9e0cc90ebde4/bmjopen-2021-057852f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/9378945/3a9a2e5d152f/bmjopen-2021-057852f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/9378945/53341f6c4f86/bmjopen-2021-057852f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/9378945/464f02fa0cd9/bmjopen-2021-057852f04.jpg

相似文献

1
Diagnostic yield of screening for SARS-CoV-2 among patients admitted to hospital for alternate diagnoses: an observational cohort study.针对因其他诊断而住院的患者进行 SARS-CoV-2 筛查的诊断收益:一项观察性队列研究。
BMJ Open. 2022 Aug 10;12(8):e057852. doi: 10.1136/bmjopen-2021-057852.
2
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
3
Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.首诊于医院患者的 SARS-CoV-2 核酸扩增检测的灵敏度和诊断收益。
JAMA Netw Open. 2022 Oct 3;5(10):e2236288. doi: 10.1001/jamanetworkopen.2022.36288.
4
CCEDRRN COVID-19 Infection Score (CCIS): development and validation in a Canadian cohort of a clinical risk score to predict SARS-CoV-2 infection in patients presenting to the emergency department with suspected COVID-19.CCEDRRN COVID-19 感染评分(CCIS):在加拿大疑似 COVID-19 急诊患者队列中开发和验证用于预测 SARS-CoV-2 感染的临床风险评分。
BMJ Open. 2021 Dec 2;11(12):e055832. doi: 10.1136/bmjopen-2021-055832.
5
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.羟氯喹用于接触新冠病毒疾病(COVID-19)后成年人暴露者预防严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的暴露后预防效果:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4.
6
Intubation practices and outcomes for patients with suspected or confirmed COVID-19: a national observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN).疑似或确诊 COVID-19 患者的插管实践和结果:加拿大 COVID-19 急诊快速反应网络(CCEDRRN)的一项全国性观察性研究。
CJEM. 2023 Apr;25(4):335-343. doi: 10.1007/s43678-023-00487-1. Epub 2023 Apr 5.
7
Which parameters support disposition decision in suspected COVID-19 cases in the emergency department (ED): a German clinical cohort study.哪些参数支持急诊科疑似 COVID-19 病例的处置决策:一项德国临床队列研究。
BMJ Open. 2021 Mar 31;11(3):e044853. doi: 10.1136/bmjopen-2020-044853.
8
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
9
Treatments, resource utilization, and outcomes of COVID-19 patients presenting to emergency departments across pandemic waves: an observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN).在大流行期间,急诊科就诊的 COVID-19 患者的治疗方法、资源利用和结局:加拿大 COVID-19 急诊科快速反应网络(CCEDRRN)的观察性研究。
CJEM. 2022 Jun;24(4):397-407. doi: 10.1007/s43678-022-00275-3. Epub 2022 Apr 1.
10
Epidemiology and clinical features of emergency department patients with suspected COVID-19: Insights from Australia's 'second wave' (COVED-4).澳大利亚“第二波”疫情中急诊科疑似 COVID-19 患者的流行病学和临床特征(COVED-4)。
Emerg Med Australas. 2021 Apr;33(2):331-342. doi: 10.1111/1742-6723.13706. Epub 2021 Jan 6.

引用本文的文献

1
Accuracy of the Canadian COVID-19 Mortality Score (CCMS) to predict in-hospital mortality among vaccinated and unvaccinated patients infected with Omicron: a cohort study.加拿大 COVID-19 死亡率评分 (CCMS) 预测感染奥密克戎的接种和未接种疫苗患者住院死亡率的准确性:一项队列研究。
BMJ Open. 2024 Nov 19;14(11):e083280. doi: 10.1136/bmjopen-2023-083280.
2
Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial.法国巴黎大都市区 18 家急诊部门加强 SARS-CoV-2 筛查(DEPIST-COVID):一项集群随机、两期、交叉试验。
PLoS Med. 2023 Dec 7;20(12):e1004317. doi: 10.1371/journal.pmed.1004317. eCollection 2023 Dec.
3

本文引用的文献

1
CCEDRRN COVID-19 Infection Score (CCIS): development and validation in a Canadian cohort of a clinical risk score to predict SARS-CoV-2 infection in patients presenting to the emergency department with suspected COVID-19.CCEDRRN COVID-19 感染评分(CCIS):在加拿大疑似 COVID-19 急诊患者队列中开发和验证用于预测 SARS-CoV-2 感染的临床风险评分。
BMJ Open. 2021 Dec 2;11(12):e055832. doi: 10.1136/bmjopen-2021-055832.
2
The Impact of COVID-19 on a Large, Canadian Community Emergency Department.新冠疫情对加拿大一个大型社区急诊科的影响
West J Emerg Med. 2021 May 5;22(3):572-579. doi: 10.5811/westjem.2021.1.50123.
3
Intubation practices and outcomes for patients with suspected or confirmed COVID-19: a national observational study by the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN).
疑似或确诊 COVID-19 患者的插管实践和结果:加拿大 COVID-19 急诊快速反应网络(CCEDRRN)的一项全国性观察性研究。
CJEM. 2023 Apr;25(4):335-343. doi: 10.1007/s43678-023-00487-1. Epub 2023 Apr 5.
4
The CCEDRRN COVID-19 Mortality Score to predict death among nonpalliative patients with COVID-19 presenting to emergency departments: a derivation and validation study.CCEDRRN COVID-19 病死率评分模型预测急诊非姑息治疗 COVID-19 患者的死亡风险:一项推导验证研究。
CMAJ Open. 2022 Feb 8;10(1):E90-E99. doi: 10.9778/cmajo.20210243. Print 2022 Jan-Mar.
Development of the Canadian COVID-19 Emergency Department Rapid Response Network population-based registry: a methodology study.
加拿大 COVID-19 急诊科快速反应网络人群登记系统的开发:方法学研究。
CMAJ Open. 2021 Mar 17;9(1):E261-E270. doi: 10.9778/cmajo.20200290. Print 2021 Jan-Mar.
4
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing.美国传染病学会关于新型冠状病毒肺炎(COVID-19)诊断的指南:分子诊断检测
Clin Infect Dis. 2021 Jan 22. doi: 10.1093/cid/ciab048.
5
COVID-19 screening of asymptomatic patients admitted through emergency departments in Alberta: a prospective quality-improvement study.在阿尔伯塔省,通过急诊部门收治的无症状患者的 COVID-19 筛查:一项前瞻性质量改进研究。
CMAJ Open. 2020 Dec 18;8(4):E887-E894. doi: 10.9778/cmajo.20200191. Print 2020 Oct-Dec.
6
Yield of Screening for COVID-19 in Asymptomatic Patients Before Elective or Emergency Surgery Using Chest CT and RT-PCR (SCOUT): Multicenter Study.使用胸部CT和逆转录聚合酶链反应(RT-PCR)在择期或急诊手术前对无症状患者进行2019冠状病毒病(COVID-19)筛查的产量(SCOUT):多中心研究
Ann Surg. 2020 Dec;272(6):919-924. doi: 10.1097/SLA.0000000000004218.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.用于确定在基层医疗或医院门诊就诊的患者是否患有新冠病毒病的体征和症状。
Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD013665. doi: 10.1002/14651858.CD013665.
8
Successful implementation of preventive measures leads to low relevance of SARS-CoV-2 in liver transplant patients: Observations from a German outpatient department.成功实施预防措施可降低 SARS-CoV-2 在肝移植患者中的相关性:德国门诊观察。
Transpl Infect Dis. 2020 Dec;22(6):e13363. doi: 10.1111/tid.13363. Epub 2020 Jun 22.
9
Universal Testing for COVID-19 in Essential Orthopaedic Surgery Reveals a High Percentage of Asymptomatic Infections.在基础骨科手术中进行 COVID-19 普检揭示了高比例的无症状感染。
J Bone Joint Surg Am. 2020 Aug 19;102(16):1379-1388. doi: 10.2106/JBJS.20.01053.
10
Universal SARS-CoV-2 testing on admission to the labor and delivery unit: Low prevalence among asymptomatic obstetric patients.分娩单元入院时对所有患者进行严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测:无症状产科患者中的低流行率
Infect Control Hosp Epidemiol. 2020 Sep;41(9):1095-1096. doi: 10.1017/ice.2020.255. Epub 2020 May 27.